Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Learn which indices traders watch most closely and why. This quick primer covers the benchmarks that shape trading strategies and risk assessment.
26,463 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
YANG, the 3X inverse ETF tracking FTSE China 50, has fallen about 44% in the last year as Chinese large-caps rally. F...
Traders are turning toward three mid-cap miners as the tape says these growth stocks could ride higher metal prices a...
As Nvidia prepares to report earnings in May, investors weigh AI momentum against valuation. This practical guide exp...
A hypothetical turn of events places Kevin Warsh at the Fed helm, where rate cuts look unlikely as inflation remains ...
Wendy’s shares jumped about 27% on the CFO announcement, fueled by a Reddit-driven Save Wendy’s meme rally. Quarterly...
After eight weeks of net withdrawals, Bitcoin spot ETFs posted a rare inflow week. The swing comes as crypto prices r...
A new AI-driven marketing platform is raising Reg A+ funds at $0.85 per share, pitching a fast-growth TMT play for in...
Analysts say bitcoin’s price running same playbook is resurfacing, with a key $65,000 level in focus. A potential, if...
Massive accumulation by large holders and dwindling exchange reserves are fueling debate over a possible Bitcoin bott...
Strategy shareholders approved a plan to start semi-monthly dividends on STRC preferred stock, aiming to steady price...
Micron Technology shares tumbled about 13% ahead of its fiscal Q3 print, but one analyst argues the slide is a sentim...